The tension between early diagnosis and misdiagnosis of multiple sclerosis

Cortical Gray Matter MR Imaging in Multiple Sclerosis

(2017) Massimiliano Calabrese et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis

(2016) J.-W. Hyun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

(2016) Ilya Ayzenberg et al.   JOURNAL OF NEUROLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

(2016) MD Willis et al.   Multiple Sclerosis Journal

Circulating microRNAs as biomarkers in progressive multiple sclerosis

(2016) Julia Vistbakka et al.   Multiple Sclerosis Journal

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

(2016) Pascal Sati et al.   Nature Reviews Neurology

Disease-modifying therapies and infectious risks in multiple sclerosis

(2016) Alexander Winkelmann et al.   Nature Reviews Neurology

Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest

(2016) Arman Eshaghi et al.   NEUROLOGY

Reducing costs while enhancing quality of care in MS: Table

(2016) Ilya Kister et al.   NEUROLOGY

The contemporary spectrum of multiple sclerosis misdiagnosis

(2016) Andrew J. Solomon et al.   NEUROLOGY

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

(2016) Ludwig Kappos et al.   NEUROLOGY

Multiple Sclerosis and Antibodies against KIR4.1

(2016) Anne-Katrin Pröbstel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis

(2016) Anne Chastre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Disease modifying therapies for relapsing multiple sclerosis

(2016) Dean M Wingerchuk et al.   BMJ-British Medical Journal

Medical error—the third leading cause of death in the US

(2016) Martin A Makary et al.   BMJ-British Medical Journal

Disease modifying therapies for relapsing multiple sclerosis

(2016) Dean M Wingerchuk et al.   BMJ-British Medical Journal

Medical error—the third leading cause of death in the US

(2016) Martin A Makary et al.   BMJ-British Medical Journal

Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort

(2016) MD Willis et al.   Multiple Sclerosis Journal

Circulating microRNAs as biomarkers in progressive multiple sclerosis

(2016) Julia Vistbakka et al.   Multiple Sclerosis Journal

Brain health: time matters in multiple sclerosis

(2016) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes

(2016) Sarah Y. Lockwood et al.   EBioMedicine

Peripheral blood biomarkers in multiple sclerosis

(2015) Antonella D'Ambrosio et al.   AUTOIMMUNITY REVIEWS

A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis

(2015) Michel Toledano et al.   Current Neurology and Neuroscience Reports

Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials

(2015) A. Signori et al.   EUROPEAN JOURNAL OF NEUROLOGY

Body fluid biomarkers for multiple sclerosis—the long road to clinical application

(2015) Charlotte E. Teunissen et al.   Nature Reviews Neurology

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

(2015) D. M. Hartung et al.   NEUROLOGY

The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review

(2014) C. Odenthal et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future

(2014) Itay Raphael et al.   Expert Review of Clinical Immunology

Clinically isolated syndromes and the relationship to multiple sclerosis

(2014) Wallace J. Brownlee et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Multiple sclerosis genetics

(2014) Stephen Sawcer et al.   LANCET NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Risk stratification and mitigation in multiple sclerosis

(2014) Daniel Ontaneda et al.   Multiple Sclerosis and Related Disorders

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

(2014) Vissia Viglietta et al.   Annals of Clinical and Translational Neurology

Delay in the diagnosis of multiple sclerosis in Croatia

(2013) Ivan Adamec et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention

(2013) Andrew J. Solomon et al.   Current Neurology and Neuroscience Reports

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

(2013) Axel Petzold   JOURNAL OF NEUROIMMUNOLOGY

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude

(2013) R. Dobson et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

(2013) A. Scalfari et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

Risk evaluation and monitoring in multiple sclerosis therapeutics

(2013) Michel C Clanet et al.   Multiple Sclerosis Journal

Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients

(2013) Syrone Liu et al.   Multiple Sclerosis Journal

Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren’s syndrome

(2013) Susan S Kim et al.   Multiple Sclerosis Journal

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

(2013) Ashley H Beecham et al.   NATURE GENETICS

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

(2013) Martin Stangel et al.   Nature Reviews Neurology

Advancing the research agenda for diagnostic error reduction

(2013) Laura Zwaan et al.   BMJ Quality & Safety

The incidence of diagnostic error in medicine

(2013) Mark L Graber   BMJ Quality & Safety

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice

(2013) Mark S. Freedman et al.   Multiple Sclerosis and Related Disorders

Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis

(2012) N. Bergsland et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Patients with migraine do not have MRI-visible cortical lesions

(2012) Martina Absinta et al.   JOURNAL OF NEUROLOGY

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

(2012) Virginia Devonshire et al.   LANCET NEUROLOGY

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

(2012) Aaron E Miller et al.   Multiple Sclerosis Journal

Radiologically isolated syndrome – incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review

(2012) Tobias Granberg et al.   Multiple Sclerosis Journal

MS, MRI, and the 2010 McDonald criteria: A Canadian expert commentary

(2012) D. Selchen et al.   NEUROLOGY

Survival in MS

(2012) D.S. Goodin et al.   NEUROLOGY

"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS

(2012) A. J. Solomon et al.   NEUROLOGY

Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis

(2012) R. A. Rudick et al.   NEUROLOGY

Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis

(2012) M. A. Rocca et al.   Radiologia Medica

Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis

(2012) Antonio Scalfari et al.   JAMA Neurology

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Using atypical symptoms and red flags to identify non-demyelinating disease

(2011) Siobhan B Kelly et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice

(2011) SB Kelly et al.   Multiple Sclerosis Journal

Regional brain atrophy in children with multiple sclerosis

(2011) B. Aubert-Broche et al.   NEUROIMAGE

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

(2010) O. Fernández et al.   JOURNAL OF NEUROLOGY

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

(2010) Elaine Kingwell et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The McDonald Criteria for Multiple Sclerosis: time for clarification

(2010) Christopher H Hawkes et al.   Multiple Sclerosis Journal

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

(2009) M. Hutchinson et al.   JOURNAL OF NEUROLOGY

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

Relapses in multiple sclerosis are age- and time-dependent

(2008) H Tremlett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence

(2008) A Boster et al.   Multiple Sclerosis Journal

Differential diagnosis of suspected multiple sclerosis: a consensus approach

(2008) DH Miller et al.   Multiple Sclerosis Journal

Comorbidity delays diagnosis and increases disability at diagnosis in MS

(2008) R. A. Marrie et al.   NEUROLOGY

Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome

(2008) D. T. Okuda et al.   NEUROLOGY